Bio-Rad Laboratories Inc

BIONYSE · USD
376.41USD0.00 (-1.57%)
659

Bio-Rad Laboratories Inc (BIO) Implied Volatility Current

BIO implied volatility is 29%. IV Rank is 3%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking BIO implied volatility helps you identify when options premiums on Bio-Rad Laboratories Inc are historically cheap or expensive, and where the best trades are hiding. Bio-Rad Laboratories Inc implied volatility reflects the market's expectation of future price movement: when BIO IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Bio-Rad Laboratories Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For BIO, tracking metrics like BIO IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on BIO signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety.

This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where BIO implied volatility sits today versus where it has been. Our scanner ranks Bio-Rad Laboratories Inc implied volatility against its historical range, surfaces extremes in BIO IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Bio-Rad Laboratories Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
3.17%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)29.02%

IV Rank3.17%

Historical Volatility (30d)23.39%

IV - HV+5.63%

As of September 18, 2026

Trade options with IV on your side

Track BIO IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial